|Bid||68.79 x 1000|
|Ask||68.83 x 800|
|Day's Range||67.79 - 69.85|
|52 Week Range||43.10 - 85.40|
|Beta (5Y Monthly)||2.23|
|PE Ratio (TTM)||15.74|
|Earnings Date||Feb 07, 2024 - Feb 12, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 13, 2000|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for THC
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund returned -6.16% (net) compared to a -4.78% return for the Russell 2500 Index. Furthermore, the fund underperformed its secondary benchmark, the Russell 2500 Value Index, […]
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In a notable insider transaction, Director Richard Fisher sold 6,000 shares of Tenet Healthcare Corp (NYSE:THC) on November 22, 2023.